The aim of this study was to compare novel and established anthropometrical measures in their ability to predict cardiovascular disease (CVD), and to determine whether they improve risk prediction beyond classical risk factors in a cohort study of 60-year-old men and women. We also stratified the results according to gender to identify possible differences between men and women. Furthermore, we aimed to replicate our findings in a large independent cohort (The Malmö Diet and Cancer study-cardiovascular cohort).
INTRODUCTION
Obesity is one of the leading risk factors for mortality in high-and middle-income countries, 1 and may be the main upstream driver of cardiometabolic risk. Traditionally, body mass index (BMI) has been the preferred measure of obesity; it is practical to use as to date height and weight are recorded in most data sources. 2 However, stronger associations with cardiovascular outcomes have been shown with other mediators of the impact of excess body fatness (and its various types of measures) on CVD risk; waist-hip ratio (WHR) compared with BMI in the eighties, 3, 4 and WHR as well as waist circumference (WC) was shown to be of greater importance than BMI in the myocardial infarction casecontrol INTERHEART study. 5 Thus, it has been suggested that measurement of BMI should be complemented by WHR or WC in the prediction of mortality, as these measures more specifically target abdominal obesity. 6 By contrast, the Emerging Risk Factors Collaboration investigated the effects of BMI, WC, and WHR in pooled data from 58 cohorts and showed no improvement in prediction beyond classical risk factors (blood pressure, diabetes, smoking and lipids) for cardiovascular disease (CVD). 7 However, the results were not presented in separate models for men and women, and novel anthropometric measures were not evaluated in this large collaborative study.
Recently, a cross-sectional study investigated suitable cutoff levels to identify individuals at high cardiometabolic risk based on their BMI, WHR, WC or sagittal abdominal diameter (SAD). 8 A new anthropometric measure, waist-hip-height ratio (WHHR; WHR divided by height), that reflects central obesity was shown to be superior to WHR in predicting all-cause mortality. 9 WC-to-height ratio (WCHR), 10, 11 and SAD-to-height ratio (SADHR) are also anthropometric measures of potential interest. It is possible that these new measures contain information that may improve model prediction, which could be useful in the prevention of CVD.
Thus, the aim of this study was to compare BMI, WHR, WC, SAD, WHHR, WCHR and SADHR in their ability to predict ischemic CVD, and to determine whether they improve risk prediction beyond classical risk factors in an 11-year follow-up of a community-based cohort of 60-year-old individuals. We also stratified the results according to gender to identify possible differences between men and women. Furthermore, we aimed to validate our findings from this group of 60-year-old men and women in a large independent cohort (The Malmö Diet and Cancer study-cardiovascular cohort).
SUBJECTS AND METHODS

Main study population
The cohort of 60-year-old men and women. All men and women living in Stockholm County who were born between 1 July 1937 and 30 June 1938 were identified from a register of the population in Sweden. From August 1997 to March 1999, every third individual (male or female) was invited to participate in a thorough cardiovascular and metabolic health screening. Of the 5460 citizens of Stockholm County invited to participate in the study, 4232 (78%) agreed to do so.
All participants underwent a physical examination that included collection of fasting blood samples as well as measurement of height, weight, WC, hip circumference and SAD. Systolic and diastolic blood pressures were measured twice after 5 min of rest; the mean value of the two measurements was calculated. A comprehensive questionnaire was completed by all participants. Diabetes was defined as self-reported diagnosis of diabetes, intake of anti-diabetic medication or newly diagnosed diabetes at the baseline examination as a result of fasting serum glucose X7.0 mmol l À 1 . 12 Smoking was categorized as current, former or daily. A more detailed description of the methods has been published previously. [13] [14] [15] The study was approved by the ethics committee at Karolinska Institutet, and all subjects agreed to participate.
Anthropometric measures. Height was measured without shoes to the nearest 0.5 cm. An electronic scale was used to weigh the participants to the nearest 0.1 kg. BMI was calculated as weight (kg) divided by height (m) squared.
2 WC was measured in underwear after a normal expiration with the subject standing up, at the midway point between the iliac crest and the lower rib margin. 8 Hip circumference was measured horizontally at the point of largest lateral extension at the hips or over the buttocks. The WHR was calculated as WC divided by hip circumference, and the WCHR was calculated as WC divided by height. WHHR was calculated as the WHR divided by height. SAD was measured with the subject in the supine position with straight legs on a firm examination table without clothes in the abdominal area after normal expiration, using a ruler and water level. 16 SAD was defined as the distance between the table up to the top of the body at the level of the iliac crest, and was measured to the nearest 0.1 cm. The SADHR was calculated as SAD divided by height.
Blood analyses. Blood samples were drawn in the morning after overnight fasting. Serum glucose was measured with an enzymatic colorimetric test (Bayer Diagnostics, Tarrytown, NY, USA). Cholesterol in serum was analyzed using enzymatic methods (Bayer Diagnostics). High-density lipoprotein cholesterol in serum was measured enzymatically after isolation of low-and very-low-density lipoprotein (Boehringer Mannheim GmbH, Mannheim, Germany).
Outcome variable. The outcome in the cohort of 60-year-old men and women was a composite endpoint of incident ischemic CVD events using the In Hospital Care Register and the Cause of Death Register in Sweden. All cases of fatal and non-fatal myocardial infarction, ischemic stroke and hospitalization due to angina pectoris as the primary cause were included in the incident first-time ischemic CVD outcome (International Classification of Diseases 10th revision (ICD-10) codes: I20, I21, I25, I46, I63, I64, I65 and I66). Heart failure and hemorrhagic stroke were not included as they are not necessarily caused by atherosclerosis.
Replication cohort
The Malmö Diet and Cancer (MDC) study-cardiovascular cohort (MDC-CC) 17 was used to replicate the findings from the main study cohort of 60-year-old men and women from Stockholm. A total of 6103 men and women (mean age 58±6 years; 40% men) from the populationbased MDC cohort were invited to take part in a substudy of the epidemiology of CVD. Baseline examinations were performed between 1991 and 1994. Height, weight, WC and hip circumference were measured in a similar manner as described above for the Stockholm cohort (further details have been reported elsewhere 18 ). After exclusion of subjects with missing information for one or more of the variables used in this study, 5180 subjects remained in the analysis.
All subjects were followed until first cardiovascular event, death, emigration from Sweden, or 31 December 2008, whichever came first. Incidence of cardiovascular events was defined as fatal or non-fatal myocardial infarction (ICD 9th revision (ICD-9) and ICD-10 codes 410 and I21, respectively), stroke (ICD-9 codes 430, 431 and 434; ICD-10 codes 436, I60, I61, I63 and I64), or death due to ischemic heart disease (ICD-9 codes 412 and 414 and ICD-10 codes I22 and I23). 19 All participants provided written informed consent and the study was approved by the Ethical Committee at Lund University, Lund, Sweden.
Statistical analysis
We calculated the median and interquartile intervals to characterize the participants. Differences in medians were calculated using the BonnetPrice s.e. (http://fmwww.bc.edu/repec/bocode/b/bpmedian.ado). Differences in frequencies were calculated with w 2 -tests. As the anthropometric measures were normally distributed, we calculated hazard ratios (HRs) and 95% confidence intervals (CIs) for incident CVD per s.d. increment, using Cox proportional hazards models adjusted for smoking and education. To enable direct comparison with the recent study by the Emerging Risk Factors Collaboration of the effects of BMI, WC, and WHR in pooled data from 58 cohorts, 7 statistical adjustments were made for the same established risk factors: systolic blood pressure, total and high-density lipoprotein (HDL)-cholesterol (continuous covariates), presence of diabetes at baseline (yes/no) and smoking.
Several tests were performed on the anthropometric variables to determine model discrimination as well as how much each of the measures could add to the prediction of incident CVD. Model discrimination was quantified by the C-statistic for Cox regression, which can be interpreted as the area under the receiver operating characteristic curve for a corresponding logistic regression model. 20 We also calculated a delta C-statistic, defined as the increment in C-statistic when each anthropometric measure is added to a model with established CVD risk factors. Likelihood ratio tests were conducted to determine whether the Cox regression models improved significantly with the anthropometric measure added to a model with established CVD risk factors. 21 Net reclassification improvement (NRI) was calculated 22 (Programs and instructions used for the calculation of NRI in Stata, SAS and R are those available on the Uppsala University website: http://www.ucr.uu.se/sv/ downloads). 23 The NRI is based on reclassification tables for individuals with and without events, and determines whether more or fewer individuals are correctly classified with the anthropometric measure added to a model with established CVD risk factors; this information cannot be obtained from simple adjustments to Cox regression models. Risk cutoff levels must be defined in NRI calculations to mirror groups for which the 10-year CVD risk leads to different clinical decisions; the cutoff levels used in the present study were o5%, 5-10% and 410%, based on the SCORE project. 24 Stata 11 software (Stata Corporation, College Station, TX, USA) was used for all calculations.
RESULTS
During the 11-year follow-up (median time, 10.85 years) in the national Swedish registers, an incident ischemic CVD event was recorded in 240 men and 135 women. Table 1 shows the median values and interquartile intervals for the anthropometric measures and covariate factors in men and women with and without CVD. Individuals with higher BMI, WHR, WC, SAD, WHHR, WCHR and SADHR had more CVD risk factors and were more likely to develop CVD during follow-up. Tables 2a and 2b shows Cox regression (confounder as well as CVD risk factor-adjusted) models for one s.d. increase of each anthropometric measure, in men and women separately. Besides height, increments in all measures were significantly associated with higher risk of incident ischemic CVD in confounder-adjusted models, but BMI seemed to have less effect than the other measures in women. WHHR had the highest model discrimination in confounder-adjusted models among both men and women (C-statistic, 0.6591 and 0.6306, respectively). BMI had substantially lower model discrimination among women (C-statistic, 0.6041) compared with the other measures.
WHHR, SAD and SADHR were the only anthropometric measures that remained significant after adjustments for established CVD risk factors in men: HRs 1.19 (95% CI 1.05-1.36), 1.16 (95% CI 1.02-1.30), and 1.19 (95% CI 1.07-1.32), respectively. By contrast, WHHR was the only measure that predicted CVD risk in women (HR 1.20, 95% CI 1.01-1.43) after risk factor adjustment (Table 2b) . Significantly improved likelihood ratios were observed with WHHR (Po0.01), SAD (Po0.05) and SADHR (Po0.01) in men, but only with WHHR (Po0.05) in women.
The NRI for WHHR in women and men is shown in Tables 3a  and 3b . Significantly more men were correctly classified into a higher risk category among those having incident CVD during follow-up (0 þ 9 ¼ 9), and individuals without CVD during follow-up were classified into lower risk categories (26 þ 90 ¼ 116), when WHHR is added to a model with established risk factors (estimate 0.06479, Po0.001). In total, many women were reclassified but it was not significantly improved (estimate 0.05951, P ¼ 0.060). Table 4 shows Cox regression models for BMI, WHR, WC and WHHR in the MDC-CC. We confirmed that besides height, all anthropometric measures predict incident CVD in confounderadjusted models. The model discrimination values were slightly higher as compared with the cohort of 60-year-old men and women. In men, only WHHR remained significant in models adjusted for established CVD risk factors (HR 1.16, 95% CI 1.04-1.30). Similarly, the likelihood ratio was only significant for WHHR in men (P ¼ 0.01). Case, incident ischemic stroke or coronary heart disease during the 11-year follow-up. 
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DISCUSSION
Main findings
Overall, WHR and SAD and their corresponding ratio to height (that is, WHHR and SADHR, respectively) appeared stronger predictors of CVD risk than BMI, WC and WCHR. The new adiposity measure, WHHR, added more model discrimination beyond the conventional risk factors systolic blood pressure, total cholesterol, HDL cholesterol, smoking and diabetes than other anthropometric measures in the community-based cohort of 60-year-old men and women. This was consistent among both men and women in stratified analyses. Besides height in women, the models adjusted for education and smoking were significant for all measures. We were also able to verify that WHHR improves prediction after adjustment for established CVD risk factors in men but not women in an independent large community-based cohort.
Comparison with other studies Besides height in women, all anthropometric measures were associated with incident CVD in models adjusted for smoking and education; which may be explained by the strong association between obesity and cardiometabolic risk factors. 8 The highest model discrimination and the most improved likelihood ratio in models adjusted for established risk factors were observed with WHHR. These findings are in agreement with the results of a study of 33 531 individuals showing that WHHR was superior to WHR in predicting all-cause mortality. 9 Furthermore, there was a Abbreviations: CVD, cardiovascular disease; WHHR, waist-hip-height ratio. The CVD model was adjusted for total cholesterol, high-density lipoprotein-cholesterol, systolic blood pressure, diabetes and smoking at baseline. The estimated net reclassification improvement was 0.05951 (P ¼ 0.060). Reclassification of women, when WHHR is added to a model with established CVD risk factors.
Utility of anthropometry in CVD risk prediction AC Carlsson et al significant improvement in risk reclassification as evaluated by NRI for WHHR, when WHHR was added to a model with established CVD risk factors. SAD has previously been shown to predict CVD in each BMI interval, 25 and our unadjusted data confirm the clinical feasibility of this parameter, as the unadjusted HR for a s.d. increase was significant in both men and women. In line with previous cross-sectional analyses of the present cohort, SAD appears to be a stronger predictor of incident CVD in men than in women, 8 and thus may be a more useful screening tool in men. This gender difference was also observed with SADHR. WHR and WC was superior to BMI in the case-control INTERHEART study of risk of myocardial infarction, 5 as confirmed in our study especially among women.
Potential mechanisms There are several potential mechanisms that may explain our findings. The previously shown high correlation between WC and hypertension, 13 hypertension control, 15 and metabolic disturbances, 14 as well as the superiority of SAD in identifying cardiometabolic risk in the cohort of 60-year-old men and women, 8 although not shown in all other elderly cohorts, 26 may explain why the effects were small after adjustments for the known highly associated CVD risk factors (systolic blood pressure, total cholesterol, HDL cholesterol, smoking and diabetes).
Bjorntorp et al. suggested that hypothalamic arousal syndrome with parallel activation of the hypothalamic-pituitary-adrenal (HPA) axis and the central sympathetic nervous system is responsible for development of endocrine abnormalities including, but not restricted to, insulin resistance, central obesity, dyslipidemia, hypertension and type 2 diabetes. 27 In addition, it has been shown that activation of the HPA axis is associated with visceral adiposity observed with a high WHR in women. 28 WHHR remained a significant predictor of CVD risk after adjustment for established risk factors in men and women in the cohort of 60-year-old men and women, whereas significance was only seen in men in the MDC-CC. This may be partly explained by the necessary age adjustments in the latter study, and may also explain why several measures were significant after adjustments for established CVD risk factors in men in the Stockholm cohort in contrast to findings from the Emerging Risk Factors Collaboration with pooled data from 58 cohorts. 7 The superiority of measures that capture abdominal adiposity as predictors of CVD and all-cause mortality may be explained by a higher degree of inflammation in the abdominally obese. Abdominal fat is known to produce inflammatory cytokines, which have been associated with increased CVD risk, 29 and this may partly explain the stronger associations between CVD and SAD, WHR, WHHR, WCHR and SADHR in crude models, compared with BMI.
Genome-wide association studies have shown that the genes associated with WHR differ from those associated with BMI and that there is a sexual dimorphism in the genes associated with WHR. 30 These findings may explain some of the gender differences in the associations with incident ischemic CVD.
Clinical implications
The finding that SAD, WHR, WHHR, WCHR and SADHR appeared to be more strongly associated with CVD than BMI may be of importance, as an increase in abdominal fat accumulation may not be recognized by BMI. [31] [32] [33] Furthermore, the strong association between these measures and the established CVD risk factors imply that abdominal obesity may progress in individuals with low fitness and/or physical inactivity and that this chain may be the main upstream driver of cardiovascular events. Thus, efforts should be made in society to decrease our sedentary lifestyle.
A disadvantage of WHHR compared with the other anthropometric variables may be that it is not as simple to use in clinical practice, as it includes three different measurements and thus takes longer to measure and calculate. Further studies are therefore needed before the clinical use of WHHR could be recommended. WC and SAD are the simplest variables, as they only require one measurement each and no calculations.
No pharmacological treatment that reduces weight in obese individuals has been shown to reduce cardiovascular events. In fact, a risk increase was seen with sibutramine in a 3.5-year trial. 34 However, the anti-diabetic drug pioglitazone that redistributes fat has been shown to reduce serious CVD events in secondary prevention. 35 Thus, obesity measures such as WHHR that portray body composition and are highly associated with CVD outcomes may be ideal targets for lifestyle and pharmacological interventions.
Although the traditional obesity measures were non-significant after adjustments for established cardiovascular risk factors, we do not claim them unimportant. In fact, obesity may be the most important upstream factor predisposing diabetes, hypertension and dyslipidemia.
Strengths and limitations Extrapolation of the results from the cohort of 60-year-old men and women to other age groups should be made with caution. However, the inclusion of only 60-year-old individuals excludes potential age bias, which is an advantage because CVD and cardiometabolic risk factors are largely age dependent. Additionally, we verified our findings in another cohort, the MDC study, in which a wider age range was included. However, when comparing results between the cohorts, the fact that measurements of SAD and SADHR were not available in the MDC cohort should be taken into consideration.
The current study has several strengths. First, it includes data from multiple anthropometric variables, including unconventional measures such as WHHR, SAD and SADHR. The cohort of 60-yearold men and women is population based with a high participation rate and includes both men and women. The latter is of importance because gender differences in cardiometabolic factors have repeatedly been shown in this, 8, [13] [14] [15] and other studies. 36, 37 A second strength is the follow-up using Swedish registers with nearly complete data (99.7%) on the studied outcomes. 38 Finally, we were able to verify the finding that WHHR is a significant predictor of CVD risk in men in an independent community-based Swedish cohort. However it should be noted that there was a slight difference in the CVD outcomes of the two cohorts; in contrast to the Stockholm cohort, MDC-CC included hemorrhagic stroke, which is a relatively rare event.
CONCLUSIONS
The unadjusted risk prediction was significant for all measures indicating an important role of anthropometry in screening for individuals at risk of CVD. Overall, BMI, WC and WCHR were weaker predictors than WHR and SAD and their corresponding ratios with height (WHHR and SADHR, respectively). In line with previous cross-sectional analyses of this cohort, SAD and SADHR seem to be especially strong predictors among men. It is interesting that WHHR appears to have the highest risk estimates among the anthropometric measures, at least in men. Further studies are needed to confirm these results in non-Scandinavian populations.
